Search Browse Earnings

GeoVax Labs, Inc. — SlamSEC

GeoVax Labs, Inc.

Nasdaq:GOVX

Pharmaceutical Preparations·SMYRNA, GA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

-100.0% YoY

FY 2024

Adj. EBITDA

-$26.7M

FY 2024

Net Income

-$26.0M

FY 2024

EPS (Diluted)

-$14.29

FY 2024

Stock Price

$1.78

+0.0%

2026-03-06

52W Range

$1.26 – $47.13

P/E Ratio

-0.1x

Market Cap

$52.9M

Cash

$6.5M

FY 2024

Total Debt

$198,064

FY 2021

Net Cash

$6.3M

FY 2021

Enterprise Value

$46.6M

Debt / EBITDA

0.2x

FY 2024

EV / EBITDA

-1.7x

Employees

—